Daiken Medical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Keiichi Yamada
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 21.8yrs |
| CEO ownership | 19.0% |
| Management average tenure | no data |
| Board average tenure | 5.5yrs |
CEO
Keiichi Yamada (67 yo)
Mr. Keiichi Yamada has been the President at Daiken Medical Co., Ltd. since March 2004 and has been its Chief Executive Officer since January 2019. He served as General Manager of Technology Division of Da...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 21.8yrs | no data | 19.01% ¥ 2.4b | |
| Executive VP | 43.4yrs | no data | no data | |
| Independent Outside Director | 9.5yrs | no data | 0.017% ¥ 2.2m | |
| Full Time Auditor | 4.5yrs | no data | 0.031% ¥ 4.0m | |
| Independent Outside Director | 4.5yrs | no data | no data | |
| Auditor | 5.5yrs | no data | no data | |
| Auditor | 5.5yrs | no data | no data |
Experienced Board: 7775's board of directors are considered experienced (5.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/05 12:04 |
| End of Day Share Price | 2025/12/05 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Daiken Medical Co., Ltd. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Masatoshi Nagata | Ichiyoshi Research Institute Inc. |
| Kosuke Sahara | Marusan Securities Co. Ltd. |
| Hidekatsu Watanabe | Mizuho Securities Co., Ltd. |